Abstract

BackgroundBarrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The numerous molecular events may play a role in the neoplastic transformation of Barrett’s mucosa such as the change of DNA ploidy, p53 mutation and alteration of adhesion molecules. However, the molecular mechanism of the progression of BE to EA remains unclear and most studies of mitochondrial DNA (mtDNA) mutations in BE have performed on BE with the presence of dysplasia.Methods/FindingsThus, the current study is to investigate new molecular events (Barrett’s esophageal tissue-specific-mtDNA alterations/instabilities) in mitochondrial genome and causative factors for their alterations using the corresponding adjacent normal mucosal tissue (NT) and tissue (BT) from 34 patients having Barrett’s metaplasia without the presence of dysplasia. Eighteen patients (53%) exhibited mtDNA mutations which were not found in adjacent NT. mtDNA copy number was about 3 times higher in BT than in adjacent NT. The activity of the mitochondrial respiratory chain enzyme complexes in tissues from Barrett’s metaplasia without the presence of dysplasia was impaired. Reactive oxygen species (ROS) level in BT was significantly higher than those in corresponding samples.Conclusion/SignificanceHigh ROS level in BT may contribute to the development of mtDNA mutations, which may play a crucial role in disease progression and tumorigenesis in BE.

Highlights

  • Patients with Barrett’s esophagus (BE) have a 30 to 125-fold higher risk of developing esophageal adenocarcinoma (EA) than those without this lesion

  • Results mitochondrial DNA (mtDNA) Sequence Alterations In a set of analyses of the mtDNA control region obtained from adjacent normal mucosal tissue (NT) and Barrett’s metaplasia tissue (BT), characteristic heteroplasmic substitution mutations in the mtDNA control region were observed in two patients (6%), respectively (Table 1, Fig. 1). mtDNA length heteroplasmic mutation at poly C stretch of 303 poly C, 16189 poly C and 514 (CA) repeat were observed in 18 patients (53%) (Table 1, Fig. 2)

  • A gene scan showed length heteroplasmies in 303 poly C, 16189 poly C and 514 CA repeats which were confirmed by TA cloning

Read more

Summary

Introduction

Patients with Barrett’s esophagus (BE) have a 30 to 125-fold higher risk of developing esophageal adenocarcinoma (EA) than those without this lesion. The presence of BE confers a 0.5,1% per year risk of the development of EA [1,2,3,4,5]. Progression to esophageal cells to cancer follows the metaplasia-dysplasiaadenocarcinoma sequence. The molecular mechanism of the progression of BE to EA remains unclear. Barrett’s esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma (EA). The molecular mechanism of the progression of BE to EA remains unclear and most studies of mitochondrial DNA (mtDNA) mutations in BE have performed on BE with the presence of dysplasia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call